State Attorneys General Investigate PBM Influence Over Health Plans Amid Concerns of Self-Benefit

State Attorneys General are expressing concerns regarding potential conflicts of interest within the pharmacy benefit manager (PBM) industry. These concerns center on the influence PBMs may exert over health plan designs and the resulting impact on the distribution and pricing of prescription medications. Specifically, the Attorneys General are scrutinizing business practices that could allow PBMs to prioritize their own financial interests. This raises questions about whether PBMs may be structuring health plan formularies and negotiating drug prices in ways that benefit themselves, potentially at the expense of patients and independent pharmacies. The AGs are focusing on whether this dominance distorts the market and reduces competition, leading to higher costs and limited choices for consumers.

Newsflash | Powered by GeneOnline AI
Date: April 15, 2025

Related posts:

CDMO Partnerships Accelerate Product Timelines, Reduce Costs, and Improve Quality Generic Pharma Mergers Surge Amid Evolving Market Report: Strategic Patent Extensions Could Add Billions to Pharmaceutical Revenue Rocatinlimab Highlighted in GlobalData Analysis as Potential New Approach for Moderate-to-Severe Atopic Dermatitis Treatment

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後